- Home
- UVV vs ATRC Comparison
UVV vs ATRC Comparison
Compare UVV & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVV
- ATRC
- Stock Information
- Founded
- UVV 1886
- ATRC 2000
- Country
- UVV United States
- ATRC United States
- Employees
- UVV N/A
- ATRC N/A
- Industry
- UVV Farming/Seeds/Milling
- ATRC Medical/Dental Instruments
- Sector
- UVV Industrials
- ATRC Health Care
- Exchange
- UVV Nasdaq
- ATRC Nasdaq
- Market Cap
- UVV 1.3B
- ATRC 1.1B
- IPO Year
- UVV N/A
- ATRC 2005
- Fundamental
- Price
- UVV $51.72
- ATRC $39.63
- Analyst Decision
- UVV
- ATRC Strong Buy
- Analyst Count
- UVV 0
- ATRC 9
- Target Price
- UVV N/A
- ATRC $41.78
- AVG Volume (30 Days)
- UVV 149.1K
- ATRC 535.9K
- Earning Date
- UVV 02-05-2025
- ATRC 02-13-2025
- Dividend Yield
- UVV 6.27%
- ATRC N/A
- EPS Growth
- UVV 5.05
- ATRC N/A
- EPS
- UVV 4.86
- ATRC N/A
- Revenue
- UVV $2,827,901,000.00
- ATRC $447,573,000.00
- Revenue This Year
- UVV N/A
- ATRC $17.75
- Revenue Next Year
- UVV N/A
- ATRC $13.44
- P/E Ratio
- UVV $10.50
- ATRC N/A
- Revenue Growth
- UVV 6.40
- ATRC 17.56
- 52 Week Low
- UVV $45.19
- ATRC $18.94
- 52 Week High
- UVV $60.10
- ATRC $39.60
- Technical
- Relative Strength Index (RSI)
- UVV 41.19
- ATRC 72.71
- Support Level
- UVV $50.04
- ATRC $31.00
- Resistance Level
- UVV $50.94
- ATRC $34.11
- Average True Range (ATR)
- UVV 1.00
- ATRC 1.78
- MACD
- UVV -0.18
- ATRC 0.94
- Stochastic Oscillator
- UVV 36.83
- ATRC 99.59
About UVV Universal Corporation
Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.